Gold nanoparticles as a potent radiosensitizer in neutron therapy

Eun Ho Kim; Mi-Sook Kim; Hyo Sook Song; Seung Hoon Yoo; Sei Sai; Kwangzoo Chung; Jiwon Sung; Youn Kyoung Jeong; YunHui Jo; Myonggeun Yoon

doi:10.18632/oncotarget.19837

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Gold nanoparticles as a potent radiosensitizer in neutron therapy

Eun Ho Kim, Mi-Sook Kim, Hyo Sook Song, Seung Hoon Yoo, Sei Sai, Kwangzoo Chung, Jiwon Sung, Youn Kyoung Jeong, YunHui Jo and Myonggeun Yoon _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:112390-112400. https://doi.org/10.18632/oncotarget.19837

Metrics: PDF 1366 views | HTML 2395 views | ?

Abstract

Eun Ho Kim1, Mi-Sook Kim2, Hyo Sook Song3, Seung Hoon Yoo1, Sei Sai4, Kwangzoo Chung5, Jiwon Sung3, Youn Kyoung Jeong6, YunHui Jo3 and Myonggeun Yoon3

1Division of Heavy Ion Clinical Research, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

2Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

3Department of Bio-convergence Engineering, Korea University, Seoul, Korea

4Department of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, Chiba, Japan

5Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea

6Research Center for Radiotherapy, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

Correspondence to:

Myonggeun Yoon, email: [email protected]

Mi-Sook Kim, email: [email protected]

Keywords: gold nanoparticles, neutron therapy, radiosensitizer, cancer, γ-ray

Received: May 23, 2017 Accepted: July 25, 2017 Published: August 03, 2017

ABSTRACT

The purpose of this study was to investigate the potential of gold nanoparticles as radiosensitizer for use in neutron therapy against hepatocellular carcinoma.

The hepatocellular carcinoma cells lines Huh7 and HepG2 were irradiated with γ and neutron radiation in the presence or absence of gold nanoparticles. Effects were evaluated by transmission electron microscopy, cell survival, cell cycle, DNA damage, migration, and invasiveness.

Gold nanoparticles significantly enhanced the radiosensitivity of Huh7 and HepG2 cells to γ-rays by 1.41- and 1.16-fold, respectively, and by 1.80- and 1.35-fold to neutron radiation, which has high linear energy transfer. Accordingly, exposure to neutron radiation in the presence of gold nanoparticles induced cell cycle arrest, DNA damage, and cell death to a significantly higher extent, and suppressed cell migration and invasiveness more robustly. These effects are presumably due to the ability of gold nanoparticles to amplify the effective dose from neutron radiation more efficiently.

The data suggest that gold nanoparticles may be clinically useful in combination therapy against hepatocellular carcinoma by enhancing the toxicity of radiation with high linear energy transfer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19837

Publication Alerts

Research Papers:

Gold nanoparticles as a potent radiosensitizer in neutron therapy

Abstract